Armata Pharmaceuticals, Inc. Shares Outstanding

Quick Answer

Armata Pharmaceuticals, Inc. reported Shares Outstanding of 36.43 million shares for fiscal year 2025.

Armata Pharmaceuticals, Inc. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 36.43M +0.7%
2024 36.18M +0.2%
2023 36.12M -0.1%
2022 36.14M +33.3%
2021 27.11M +45.1%
2020 18.69M +88.3%
2019 9.92M +95.7%
2018 5.07M -46.6%
2017 9.50M +476.1%
2016 1.65M -72.0%
2015 5.88M +47.7%
2014 3.98M -97.8%
2013 182.54M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 3.62M -90.0% -90.0%
June 30, 2025 36.19M +0.1% +0.0%
March 31, 2025 36.19M +0.2% +0.0%
December 31, 2024 36.18M +0.2% +0.0%
September 30, 2024 36.18M +0.2% +0.1%
June 30, 2024 36.16M +0.1% +0.1%
March 31, 2024 36.13M -0.0% +0.0%
December 31, 2023 36.12M -0.1% +0.0%
  • Armata Pharmaceuticals, Inc. showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2013–2025 period, Armata Pharmaceuticals, Inc.’s shares outstanding has declined by 80.0% (from 182.54 million shares to 36.43 million shares).
  • The most recent figure is from Armata Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment